Increase in Public Awareness Spurring Growth in the Autoimmune Diseases Drugs Market in the US: Technavio Report
London, 2 July 2015: Technavio, the independent tech-focused global research firm, has published a report on the autoimmune diseases drugs market in the US 2015-2019, which is expected to grow at a CAGR of 6.17% during the forecast period of 2014-2019. The increasing prevalence of autoimmune diseases in the US region drives growth in…
